Overview

Shiga Toxin Producing Escherichia Coli (STEC) Volume Expansion

Status:
Withdrawn

Trial end date:
2021-04-01

Target enrollment:

Participant gender:

Summary

This study will provide feasibility data regarding the conduct of a clinical trail evaluating the use of early aggressive inpatient intravenous rehydration in children with Shiga Toxin producing E. coli infection.

Phase:

Phase 1

Details

Lead Sponsor:

University of Calgary

Treatments:

Shiga Toxins